Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
Investors cannot turn a blind eye to insiders as well as institutional ownership. They need to follow insider trades to determine the direction the stock is likely to take.
About 9.99% of GRTX shares are held by financial institutions. GOLDEN STATE EQUITY PARTNERS is the top corporate investor, holding 93 shares valued at $4.00. A 0% stake in Galera Therapeutics, Inc. is owned by the company. SUMMIT TRAIL ADVISORS, LLC owns 0 shares valued at -, which translates its holding of 0% of the stake in the company.
Among the GRTX insiders holding of 32.84% of the stake in company, SCHNEID YAIR, 10 percent owner, holds the largest shares of 10.72M. CHANG NANCY T, , is the second largest GRTX insider with ownership of 7.64M shares. NEW ENTERPRISE ASSOCIATES 14, L.P., 10 percent owner, stands third with possession of 4.36M shares of that stake.
| Insiders | Designation | Shares Held |
|---|
| SCHNEID YAIR | 10 percent owner | 10.72M |
| CHANG NANCY T | | 7.64M |
| NEW ENTERPRISE ASSOCIATES 14, L.P. | 10 percent owner | 4.36M |
| SOFINNOVA VENTURE PARTNERS IX, L.P. | 10 percent owner | 3.08M |
| NOVARTIS BIOVENTURES LTD | | 2.47M |
| NOVO HOLDINGS A/S | 10 percent owner | 2.46M |
| SORENSEN MEL | President and CEO | 195.03K |
| CLARUS IV-A, L.P. | 10 percent owner | 130.44K |
| BLACKSTONE CLARUS GP L.P. | 10 percent owner | 130.44K |
| WEST LINDA | director | 60K |
| BACHLEDA MARK | Chief Commercial Officer | 11K |
| DEGNAN CHRIS | Chief Financial Officer | 10K |
| ALLEVA LAWRENCE M | director | 4.05K |
| HOLMLUND JON T | Chief Medical Officer | 0 |
| SUSSMAN JOEL F. | Chief Accounting Officer | 0 |
